SAB Biotherapeutics (SABS) Asset Utilization Ratio (2021 - 2024)
SAB Biotherapeutics (SABS) posted Asset Utilization Ratio of 0.03 for Q4 2024, up 3.21% on a QoQ basis from 0.03 in Q3 2024, and down 32.33% year-over-year from 0.04 in Q1 2024.
SAB Biotherapeutics (SABS) Asset Utilization Ratio (2021 - 2024) Analysis & Trends
SAB Biotherapeutics' Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.03 for Q4 2024.
- Quarterly Asset Utilization Ratio fell 32.33% year-over-year to 0.03 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.03 (down 32.33% YoY) and the FY2024 annual result came in at 0.02, down 37.84% from the prior year.
- Asset Utilization Ratio was 0.03 for Q4 2024 at SAB Biotherapeutics, up from 0.03 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.75 in Q1 2022 and bottomed at 0.03 in Q3 2024.
- A 4-year average of 0.29 and a median of 0.16 in 2023 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio fell 24.79% — and 2023, when it tumbled 91.37%.
- SAB Biotherapeutics' Asset Utilization Ratio stood at 0.61 in 2021, then fell by 24.79% to 0.46 in 2022, then tumbled by 91.37% to 0.04 in 2023, then tumbled by 32.33% to 0.03 in 2024.
- Business Quant data shows SABS's Asset Utilization Ratio at 0.03 in Q4 2024, 0.03 in Q3 2024, and 0.04 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | SAB Biotherapeutics | 170.64 Mn | 170.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.03 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.13 |
| Jun 30, 2023 | 0.16 |
| Mar 31, 2023 | 0.27 |
| Dec 31, 2022 | 0.46 |
| Sep 30, 2022 | 0.59 |
| Jun 30, 2022 | 0.69 |
| Mar 31, 2022 | 0.75 |
| Dec 31, 2021 | 0.61 |